Donovan Douglas C, Reber Adrian J, Gabbard Jon D, Aceves-Avila Maria, Galland Kimberly L, Holbert Katheryn A, Ely Lane O, Hurley David J
Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Am J Vet Res. 2007 Jul;68(7):778-82. doi: 10.2460/ajvr.68.7.778.
To assess the effect of maternal cells or cellular components on neonatal immune responses to intracellular pathogens in calves.
15 Holstein calves.
Calves were fed whole colostrum, frozen colostrum, or cell-free colostrum within 4 hours after birth. Leukocytes were obtained from calves before feeding colostrum and 1, 2, 7, 14, 21, and 28 days after ingestion. Proliferative responses against bovine viral diarrhea virus (BVDV) and mycobacterial purified protein derivatives were evaluated. Dams received a vaccine containing inactivated BVDV, but were not vaccinated against mycobacterial antigens.
All calves had essentially no IgG in circulation at birth, but comparable and substantial concentrations by day 1. Calves that received whole colostrum had enhanced responses to BVDV antigen 1 and 2 days after ingestion of colostrum. In contrast, calves that received frozen colostrum or cell-free colostrum did not respond to BVDV. No differences were identified among the 3 groups in response to mycobacterial antigens.
Results indicated that transfer of live maternal cells from colostrum to neonatal calves enhanced responses to antigens against which the dams had previously responded (BVDV), but not to antigens to which the dams were naïve (mycobacterial purified protein derivatives). Results suggested that cell-mediated immune transfer to neonates can be enhanced by maternal vaccination.
评估母体细胞或细胞成分对犊牛细胞内病原体新生儿免疫反应的影响。
15头荷斯坦犊牛。
犊牛在出生后4小时内喂食全初乳、冷冻初乳或无细胞初乳。在喂食初乳前以及摄入初乳后1、2、7、14、21和28天从犊牛获取白细胞。评估针对牛病毒性腹泻病毒(BVDV)和分枝杆菌纯化蛋白衍生物的增殖反应。母牛接种含灭活BVDV的疫苗,但未接种针对分枝杆菌抗原的疫苗。
所有犊牛出生时循环中基本没有IgG,但到第1天时浓度相当且较高。摄入初乳后1天和2天,接受全初乳的犊牛对BVDV抗原的反应增强。相比之下,接受冷冻初乳或无细胞初乳的犊牛对BVDV无反应。在对分枝杆菌抗原的反应中,3组之间未发现差异。
结果表明,初乳中活的母体细胞转移至新生犊牛可增强对母体先前有反应的抗原(BVDV)的反应,但对母体未曾接触过的抗原(分枝杆菌纯化蛋白衍生物)则无增强作用。结果提示,母体接种疫苗可增强向新生儿的细胞介导免疫转移。